N@N

Market Maker Surveillance Report. BDCO, GBR, SGMO, DMD, ACHN, CSIQ, Winning Stocks With Lowest Price Friction For Friday, Febr

^{Published on 2012-02-17 18:00:16 - WOPRAI}
 

February 17, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 3915 companies with "abnormal" market making, 3239 companies with positive Friction Factors and 2539 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. BLUE DOLPHIN ENERGY CO (OTC:BDCO), NEW CONCEPT ENERGY INC (AMEX:GBR), Sangamo Biosciences Inc (NASDAQ:SGMO), DEMAND MEDIA INC (NYSE:DMD), ACHILLION PHARMACEUTICALS (NASDAQ:ACHN), CANADIAN SOLAR INC (NASDAQ:CSIQ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     BDCO       $1.720       19.86%       286,046         58.10%       195,286         39.67%       90,760          528     
     GBR        $0.440       19.56%       25,641          31.44%       25,180          30.87%       461             10      
     SGMO       $1.180       28.10%       715,686         57.16%       536,203         42.82%       179,483         1,521   
     DMD        $1.630       27.44%       1,032,296       36.32%       814,025         28.64%       218,271         1,339   
     ACHN       $2.290       26.17%       3,284,557       50.58%       3,156,028       48.61%       128,529         561     
     CSIQ       $0.620       17.32%       1,460,505       51.00%       1,401,767       48.95%       58,738          947     

For example, the chart above shows BDCO with a dollar gain Friday of $1.72000 and a Friction Factor of 528 shares. That means that it only took 528 more shares of buying than selling to move BDCO higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

BLUE DOLPHIN ENERGY CO (OTC:BDCO) - Blue Dolphin Energy Company, through its subsidiaries, engages in the provision of pipeline transportation and related services for producers/shippers, and exploration and production of oil and gas in the United States. Its pipeline transportation and related services include the operation of the Blue Dolphin Pipeline system, which comprise the offshore segment that transports gas and condensate, and consists of approximately 34 miles of 20-inch pipeline from a offshore platform in Galveston Area Block 288 to shore, as well as the platform in Galveston Area Block 288 and 5 field gathering lines totaling approximately 27 miles connected to the main 20-inch line; and the onshore segment consisting of approximately 2 miles of 16-inch pipeline for the transportation of gas from onshore facility to a sales point at a chemical plant complex and intrastate pipeline system tie-in in Freeport, Texas. The companys pipeline systems also include the Buccaneer Pipeline, an 8-inch liquids pipeline, which transports condensate from the onshore facility storage tanks to the company's barge-loading terminal on the Intracoastal Waterway near Freeport, Texas for sale to third parties; and the Galveston Area Block 350 Pipeline consisting of 8-inch, 13 mile offshore pipeline extending from Galveston Area Block 350 to an interconnect with a transmission pipeline in Galveston Area Block 391. In addition, it holds interests in oil and gas properties located in the western Gulf of Mexico off the Texas coast. The company was founded in 1986 and is based in Houston, Texas.

NEW CONCEPT ENERGY INC (AMEX:GBR) - New Concept Energy, Inc., through its subsidiaries, operates oil and gas wells, and mineral leases in the United States. The companys oil and gas wells are located in Athens and Meigs Counties in Ohio; and Calhoun, Jackson, and Roane Counties in West Virginia. As of December 31, 2009, its proved reserves were approximately 7.6 million Mcf of natural gas. The company also leases and operates Pacific Pointe Retirement Inn located in King City, Oregon. It provides community living with basic services, such as meals, housekeeping, laundry, 24/7 staffing, transportation, and social and recreational activities. The company was formerly known as CabelTel International Corporation and changed its name to New Concept Energy, Inc. in May 2008. New Concept Energy, Inc. was incorporated in 1991 and is based in Dallas, Texas.

Sangamo Biosciences Inc (NASDAQ:SGMO) - Sangamo Biosciences, Inc. engages in the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off; and ZFP nucleases (ZFNs), proteins that enable to modify DNA sequences in various ways. The companys principal ZFP therapeutic include SB-509, a plasmid formulation of a ZFP TF activator of the vascular endothelial growth factor-A (VEGF-A) gene that is in a Phase 2b clinical trial for the treatment of severe diabetic neuropathy; and in a Phase 2 clinical trial in for the treatment of amyotrophic lateral sclerosis, as well as in preclinical animal studies for spinal cord injury, traumatic brain injury, and stroke. It is also developing SB-728-T, a ZFN-modified T-cell product, which is in Phase 1/2 clinical trial and two Phase 1 trials for the treatment of HIV/AIDS. In addition, the company develops SB-313xTZ, a ZFN-based therapeutic that is in Phase 1 clinical trial for the treatment of glioblastoma multiforme, a type of brain cancer. Further, it has preclinical development programs of ZFP therapeutics in the areas of Parkinsons disease, hemophilia B, and neuropathic pain; and neuroregenerative programs in spinal cord injury, traumatic brain injury, and stroke. Additionally, the company has research stage programs in the areas of monogenic diseases and genetic conditions that result from a defect in a single gene, including hemophilia and other hemoglobinopathies, and immunodeficiencies. It has collaboration agreements with Sigma-Aldrich Corporation; Dow AgroSciences LLC; Pfizer Inc.; Genentech, Inc.; Open Monoclonal Technology, Inc.; and F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. The company was founded in 1995 and is headquartered in Richmond, California.

DEMAND MEDIA INC (NYSE:DMD) - Demand Media, Inc. operates as an online media company in the United States. It identifies, creates, distributes, and monetizes in-demand content. The company's content and media services include creating media content, primarily consisting of text articles and videos, and delivering together with its social media and monetization tools to the company's owned and operated and network of customer Websites. Its content and media services are delivered through the company's content and media platform, which includes its content creation studio, social media applications, and a system of monetization tools designed to match content with advertisements. The company's registrar service offering provides domain name registration and related value added service subscriptions to third parties. Demand Media, Inc. was founded in 2006 and is headquartered in Santa Monica, California.

ACHILLION PHARMACEUTICALS (NASDAQ:ACHN) - Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidate pipeline includes ACH-1625, a protease inhibitor, which is in phase 1/b clinical trials for the treatment of chronic hepatitis C infections; ACH-1095, a NS4A antagonist that is in late-stage preclinical studies for the treatment of chronic hepatitis C infections; and ACH-2684, a protease inhibitor, which is in late stage preclinical testing. The companys other product candidates comprise ACH-702, which is in preclinical stage for the treatment of serious bacterial infections; and Elvucitabine that is in phase II clinical trials for the treatment of HIV infection. The company has a collaboration arrangement with Gilead Sciences, Inc. to develop and commercialize compounds for the treatment of chronic hepatitis C, which inhibit viral replication through a mechanism of action. Achillion Pharmaceuticals, Inc. was founded in 1998 and is based in New Haven, Connecticut.

CANADIAN SOLAR INC (NASDAQ:CSIQ) - Canadian Solar Inc. engages in the design, development, manufacture, and marketing of solar power products primarily in Canada and internationally. The company offers solar cell and solar module products that convert sunlight into electricity for various uses. Its products include a range of standard solar modules for use in a range of residential, commercial, and industrial solar power generation systems. The company also designs and produces specialty solar modules and products consisting of customized modules that its customers incorporate into their products, such as solar-powered bus stop lighting; and specialty products, such as portable solar home systems and solar-powered car battery chargers. In addition, it implements solar power development projects, primarily in conjunction with government organizations to provide solar power generation in rural areas of China. The company sells its products under the Canadian Solar brand name. It offers its standard solar modules through a direct sales force and sales agents primarily to distributors, system integrators, and original equipment manufacturer customers, as well as to solar projects; and specialty solar modules and products to the automotive, telecommunications, and LED lighting sectors. The company was founded in 2001 and is based in Kitchener, Canada.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net